Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9199 USD | -0.49% | -9.81% | -34.29% |
05-09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
05-09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
Sales 2024 * | 73K 5.75M | Sales 2025 * | 4.5M 355M | Capitalization | 139M 10.97B |
---|---|---|---|---|---|
Net income 2024 * | -164M -12.91B | Net income 2025 * | -153M -12.05B | EV / Sales 2024 * | 3,636 x |
Net Debt 2024 * | 126M 9.93B | Net Debt 2025 * | 193M 15.23B | EV / Sales 2025 * | 73.9 x |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.29
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.3% |
Latest transcript on Seres Therapeutics, Inc.
1 day | -0.49% | ||
1 week | -9.81% | ||
Current month | -7.14% | ||
1 month | +57.46% | ||
3 months | -12.39% | ||
6 months | -35.22% | ||
Current year | -34.29% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 31/10/14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 21/10/20 |
Chief Tech/Sci/R&D Officer | - | 30/04/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 31/03/15 |
Director/Board Member | 68 | 03/01/23 | |
Richard Kender
BRD | Director/Board Member | 68 | 05/10/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +5.72% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
17/05/24 | 0.9199 | -0.49% | 2,009,826 |
16/05/24 | 0.9244 | -3.50% | 2,703,647 |
15/05/24 | 0.9579 | +6.92% | 3,534,433 |
14/05/24 | 0.8959 | -7.17% | 3,901,308 |
13/05/24 | 0.9651 | -5.38% | 3,464,670 |
Delayed Quote Nasdaq, May 17, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.29% | 139M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- MCRB Stock